[1]
M. do Nascimento Costa, “New simplex Type 1 lytic infection pyridine system derivative as a novel goal against Herpes”, Int J of Pharmc Res, vol. 7, no. 7, pp. 148–153, Jul. 2017, doi: 10.7439/ijpr.v7i7.3932.